Indirect Bilirubin Test

Indirect bilirubin, also called unconjugated bilirubin, is formed when your body breaks down old red blood cells. The heme portion of hemoglobin, which carries oxygen, is converted into bilirubin. At first, this bilirubin is fat-soluble, meaning it cannot dissolve in water. To travel safely through the bloodstream, it binds tightly to albumin, the most abundant protein in blood. This bound form is what we call indirect bilirubin.

The liver’s job is to take in this indirect bilirubin, attach a sugar molecule to it, and turn it into direct (or conjugated) bilirubin. Direct bilirubin is water-soluble and can be excreted into bile, eventually leaving the body through stool. If this process is disrupted, whether from liver disease, bile duct blockage, or increased red blood cell breakdown, indirect bilirubin may rise.

Indirect bilirubin levels carry a mixed story for health. On one hand, mildly higher levels appear to protect against oxidative stress, a process that damages cells and drives conditions like atherosclerosis (plaque buildup in arteries) and chronic kidney disease. Research shows that people with slightly higher bilirubin may have a lower risk of coronary heart disease, stroke, and even colorectal cancer. This protective effect is thought to come from bilirubin’s role as an antioxidant.

On the other hand, high levels can be harmful. In newborns, excessive indirect bilirubin can overwhelm the body’s binding capacity and cross the blood-brain barrier, leading to a serious condition called kernicterus, which causes brain damage. In adults with cirrhosis, high indirect bilirubin often reflects ongoing hemolysis (accelerated red blood cell breakdown) or impaired liver processing. Elevated indirect bilirubin relative to albumin is also a marker of higher risk for hepatic encephalopathy, a form of brain dysfunction caused by liver failure.

Because indirect bilirubin levels can signal both resilience and disease, context matters. A mild elevation in an otherwise healthy person may not be concerning and could even be beneficial. But in someone with liver disease, hemolytic anemia, or neurological symptoms, it can be a red flag that requires closer evaluation.